Protagenic Therapeutics, Inc.new (PTIX) Share-based Compensation (2009 - 2026)
Protagenic Therapeutics, Inc.new (PTIX) reported Share-based Compensation of $62,409 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.1% from $105,868 a year earlier and down 6.9% from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Share-based Compensation (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Protagenic Therapeutics, Inc.new's Share-based Compensation came in at $317,015, down 55.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $418,589.
- Share-based Compensation has a five-year compound annual growth rate of -22.7% (FY2021 to FY2026).
- By fiscal year, Share-based Compensation came in at $923,139 in FY2024 (+38.4%), $666,828 in FY2023 (-22.9%) and $864,681 in FY2022 (-43.1%).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Share-based Compensation since fiscal Q3 2015.
- Year over year, Share-based Compensation has now declined in each of the last three quarters.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $67,012 (Q1 2027), $91,652 (Q4 2026) and $95,942 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,305.71 Bn | 1,279.33 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 694.23 Bn | 614.09 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 528.96 Bn | 496.97 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 365.92 Bn | 328.86 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 314.95 Bn | 288.19 Bn | - | - |
| 6 | Astrazeneca | 289.15 Bn | 262.67 Bn | 13.26 Bn | - |
| 7 | Amgen | 254.11 Bn | 205.76 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 211.85 Bn | 186.96 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.73 Bn | 113.09 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -3.51 Mn | - | 62,409.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 62,409.00 |
| Jun 30, 2026 | 67,012.00 |
| Mar 31, 2026 | 91,652.00 |
| Dec 31, 2025 | 95,942.00 |
| Sep 30, 2025 | 105,868.00 |
| Jun 30, 2025 | 125,127.00 |
| Mar 31, 2025 | 236,014.00 |
| Dec 31, 2024 | 245,436.00 |
| Sep 30, 2024 | 250,403.00 |
| Jun 30, 2024 | 265,439.00 |
| Mar 31, 2024 | 161,861.00 |
| Dec 31, 2023 | 166,707.00 |
| Sep 30, 2023 | 166,707.00 |
| Jun 30, 2023 | 166,707.00 |
| Mar 31, 2023 | 166,707.00 |
| Dec 31, 2022 | 198,688.00 |
| Sep 30, 2022 | 214,679.00 |
| Jun 30, 2022 | 215,535.00 |
| Mar 31, 2022 | 235,779.00 |
| Dec 31, 2021 | 218,166.00 |
Protagenic Therapeutics, Inc.new Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();